Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

Protective neutralizing antibody titers reduce in time after COVID-19 vaccinations, as in individuals who have had COVID-19. This study aimed to evaluate the safety and immunogenicity of CoronaVac and TURKOVAC vaccines used as a booster dose after CoronaVac primary vaccination. This double-blind, ra...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human vaccines & immunotherapeutics 2022-11, Vol.18 (6), p.2122503-2122503
Hauptverfasser:	Omma, Ahmet, Batirel, Ayse, Aydin, Mehtap, Yilmaz Karadag, Fatma, Erden, Abdulsamet, Kucuksahin, Orhan, Armagan, Berkan, Güven, Serdar Can, Karakas, Ozlem, Gokdemir, Selim, Altunal, Lutfiye Nilsun, Buber, Aslihan Ayse, Gemcioglu, Emin, Zengin, Oguzhan, Inan, Osman, Sahiner, Enes Seyda, Korukluoglu, Gulay, Sezer, Zafer, Ozdarendeli, Aykut, Kara, Ates, Ates, Ihsan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Neutralizing Antibodies, Viral Booster vaccine CoronaVac Coronavirus COVID-19 COVID-19 - prevention & control Female Humans Immunogenicity, Vaccine Immunoglobulin G inactive Male SARS-CoV-2 TURKOVAC Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!